Aspire HR, Inc. – Trademark Portfolio
Entity Type: 03
Aspire HR, Inc. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 5 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 4 trademarks are registered. Notable registered marks include ASPIREHR, EMPLOYEES FIRST, and ASPIREHR EMPLOYEES FIRST. The owner is based in Dallas, TX.
5151 Belt Line Road, Suite 1125
Dallas, TX 75254
Showing of trademarks Trademarks
Trademark Classifications
Aspire HR, Inc.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Scientific and technological services; industrial analysis and research services
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Frequently Asked Questions
How many trademarks does Aspire HR, Inc. have?
Aspire HR, Inc. has 5 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 cancelled.
What trademark classes does Aspire HR, Inc. file in?
Aspire HR, Inc. files trademarks across 3 Nice Classification classes. The most active classes are Class 35 (Advertising & Business), Class 42 (Computer & Scientific), Class 9 (Computers & Electronics). Class 35 covers advertising; business management; business administration; office functions.
What are Aspire HR, Inc.'s most well-known trademarks?
Aspire HR, Inc.'s registered trademark portfolio includes well-known marks such as ASPIREHR, EMPLOYEES FIRST, and ASPIREHR EMPLOYEES FIRST. These are among 4 currently registered trademarks in the portfolio.
What is Aspire HR, Inc.'s trademark registration success rate?
Aspire HR, Inc. has a 80% trademark registration rate, with 4 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.